TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates
The University of Texas MD Anderson Cancer Center and TransCode Therapeutics, Inc. today announced a strategic alliance to advance TransCode's pipeline of RNA-targeted oncology therapeutic and diagnostic candidates.
Source: news-medical.net